Taylor Wealth Management Partners Has $3.57 Million Stake in CryoPort Inc (CYRX)
Taylor Wealth Management Partners lifted its position in CryoPort Inc (NASDAQ:CYRX) by 5.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 415,575 shares of the consumer goods maker’s stock after purchasing an additional 21,935 shares during the quarter. CryoPort accounts for approximately 1.5% of Taylor Wealth Management Partners’ holdings, making the stock its 28th biggest holding. Taylor Wealth Management Partners’ holdings in CryoPort were worth $3,570,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Creative Planning acquired a new position in CryoPort during the 4th quarter worth about $5,176,000. Bank of Montreal Can acquired a new position in CryoPort during the 4th quarter worth about $142,000. Wolverine Trading LLC acquired a new position in CryoPort during the 3rd quarter worth about $230,000. Royce & Associates LP acquired a new position in CryoPort during the 3rd quarter worth about $1,351,000. Finally, Allianz Asset Management GmbH acquired a new position in CryoPort during the 3rd quarter worth about $1,120,000. 20.52% of the stock is currently owned by institutional investors and hedge funds.
Shares of CryoPort Inc (NASDAQ CYRX) traded down $0.07 during midday trading on Thursday, reaching $8.83. 10,802 shares of the company traded hands, compared to its average volume of 106,338. The firm has a market cap of $229.87, a P/E ratio of -17.18 and a beta of 0.99. CryoPort Inc has a 1-year low of $1.96 and a 1-year high of $10.40.
Separately, Roth Capital initiated coverage on shares of CryoPort in a research report on Thursday, November 30th. They set a “buy” rating and a $12.50 price target on the stock. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. CryoPort has an average rating of “Buy” and an average target price of $33.50.
CryoPort Company Profile
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.